Kybella may be right for you if:
- You’re bothered (unhappy, self-conscious, embarrassed) by fat under the chin, also known as submental fullness
- You feel the condition makes you look older or heavier than you actually are
- You don’t want to have surgery
- You eat well and exercise, but submental fullness does not go away
HOW KYBELLA® WORKS
The active ingredient in KYBELLA® is synthetic deoxycholic acid. Deoxycholic acid is a naturally occurring molecule in the body that aids in the breakdown and absorption of dietary fat. When injected into the fat beneath the chin, KYBELLA® destroys fat cells, resulting in a noticeable reduction in fullness under the chin. Once destroyed, these cells can no longer store or accumulate fat, so further treatment is not expected once you reach your desired aesthetic goal.
We recommend that most patients receive at least two treatments for an optimal result. But everyone’s chin profile is different, the number of treatments can vary from patient to patient. At you consultation, we will help you determine how many treatment sessions you need based on the amount and distribution of your submental fat and your personal treatment goals. Each KYBELLA® treatment session is given at least 1 month apart, and you should need no more than 6 treatments.
WILL I NEED TIME TO RECOVER?
After KYBELLA® treatment, you will likely have some swelling, bruising, or numbness under your chin.
WHAT ARE THE POSSIBLE SIDE EFFECTS?
You can expect the following:
- Areas of hardness
Ready to take the next step? Schedule your consultation now!
Meet Dr. Edward Ricciardelli
Dr. Edward Ricciardelli is one of the most highly trained plastic surgeons in the country. He is the only plastic surgeon in the area who is board certified in both head, neck, and facial surgery and plastic surgery. He has been performing facial surgery for over 29 years. During that time he has taught and trained other plastic and facial surgeons, lectured around the country, given courses on facial surgery, and cared for thousands of surgical patients. Read more…